Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Director Share Dealing

28 Jun 2010 07:00

RNS Number : 2973O
Chamberlin PLC
28 June 2010
 



CMH

28 June 2010

 

 

Chamberlin plc

 

("Chamberlin" or "the Company")

 

Director's share dealing

 

Chamberlin was notified on 25 June 2010 that Tom Brown, Non-executive Chairman of the Company, has acquired 15,000 new Ordinary 25p Shares in the Company at a purchase price of 74p per share.

 

Mr Brown's resultant shareholding following this transaction is 35,000 shares, representing approximately 0.47% of the total issued share capital of the Company.

 

For further information, please contact:

 

Chamberlin plc

T: 01922 707100

Tim Hair, Chief Executive

Mark Bache, Finance Director

Charles Stanley Securities Nominated Adviser

T: 020 7149 6000

Russell Cook / Luke Webster

Biddicks

T: 020 7448 1000

Katie Tzouliadis

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBLGDLGDDBGGU
Date   Source Headline
11th Mar 20215:21 pmRNSHolding(s) in Company
10th Mar 202110:41 amRNSHolding(s) in Company
10th Mar 202110:38 amRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
8th Mar 20211:30 pmRNSResult of Meeting and Directorate Change
19th Feb 20217:00 amRNSConvertible Loan and Notice of General Meeting
21st Jan 20217:00 amRNSTrading Statement
4th Jan 20217:30 amRNSSuspension - Chamberlin Plc
18th Dec 20205:43 pmRNSPublication of Audited Accounts
16th Dec 202011:55 amRNSTrading Update
27th Nov 20207:00 amRNSPublication of Audited Accounts
24th Nov 20207:15 amEQSHardman & Co Research: Chamberlin (CMH): Trading update ‒ main businesses performing solidly
23rd Nov 20207:00 amRNSTrading Update
6th Nov 20207:00 amRNSPublication of Audited Accounts
29th Sep 202010:42 amEQSHardman & Co Research: Chamberlin (CMH): Trading update most encouraging
29th Sep 20207:00 amRNSPublication of 2020 Accounts and Trading Update
23rd Jul 20205:48 pmRNSHolding(s) in Company
19th Jun 202012:15 pmRNSTrading Update
30th Mar 202012:45 pmEQSHardman & Co Research: Chamberlin Plc (CMH): Trading stalled in these unprecedented times
27th Mar 20202:24 pmRNSTrading Update
18th Feb 20203:20 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSHolding(s) in Company
17th Feb 202011:52 amEQSHardman & Co Research: Chamberlin Plc (CMH): Near-term trading subdued
13th Feb 20205:53 pmRNSTrading Statement
6th Dec 20197:01 amRNSContract award for Walsall foundry
6th Dec 20197:00 amRNSContract award for Scunthorpe foundry
22nd Nov 20197:00 amRNSHolding(s) in Company
19th Nov 201911:55 amEQSHardman & Co Research: Chamberlin Plc (CMH): Management actions yield cautious optimism
18th Nov 20197:00 amRNSHalf-year Report
4th Nov 20197:00 amRNSNotice of Interim Results
21st Oct 20191:01 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSHolding(s) in Company
23rd Jul 20194:05 pmRNSResult of AGM
23rd Jul 20197:00 amRNSBoard Retirement
23rd Jul 20197:00 amRNSAGM Statement
19th Jun 201910:14 amRNSHolding(s) in Company
4th Jun 20197:31 amEQSHardman & Co Research: Chamberlin (CMH): Trading remains difficult; forecasts lowered
4th Jun 20197:00 amRNSFinal Results
30th May 201912:35 pmRNSTrading Update
21st Feb 20192:23 pmRNSHolding(s) in Company
6th Feb 20192:06 pmEQSHardman & Co Research: Chamberlin (CMH): Trading very difficult; forecasts lowered
5th Feb 20197:52 amRNSTrading Update
24th Dec 20187:00 amRNSHalf-year Report
20th Dec 20187:00 amRNSSale of Exidor Limited
12th Dec 20187:00 amRNSChange of Adviser
12th Nov 20187:00 amRNSAppointment of Finance Director
2nd Aug 20187:00 amRNSDirectorate Change
24th Jul 20182:57 pmRNSResult of AGM
24th Jul 20187:00 amRNSAGM Statement
19th Jun 20183:39 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.